Patents by Inventor Levent Oner

Levent Oner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING OTILONIUM BROMIDE AND SIMETHICONE WITH CERTAIN BULK DENSITY AND IMPROVED DISSOLUTION CHARACTERISTICS
    Publication number: 20180311201
    Abstract: The present invention relates to a pharmaceutical composition for oral use comprising therapeutically effective amount of otilonium bromide in combination with therapeutically effective amount of simethicone, wherein the composition possesses certain bulk density and improved dissolution characteristics. Wherein a final blend prior to compression has a bulk density of at least 0.35 g/mL, and at least 85% of the otilonium bromide is released in 15 minutes in each of 0.1 N HCl, pH 4.5 and pH 6.8 buffer solutions at 37±0.5° C. using USP type II (paddle) apparatus rotating at 50 rpm.
    Type: Application
    Filed: June 12, 2015
    Publication date: November 1, 2018
    Applicant: SANTA FARMA ?LAÇ SANAY? A. ?.
    Inventors: Ahmet GÛN, Banu Öztuna, Bayram Kanik, Ediz AKZOY, Levent ÜNVER, Levent ÖNER
  • Modified release pharmaceutical compositions of dexlansoprazole
    Patent number: 9114085
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: August 25, 2015
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Ezetimibe compositions
    Patent number: 9095515
    Abstract: This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: August 4, 2015
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Levent Oner, Ali Turkyilmaz, Ibrahim Murat Uzer, Gaye Ramazanoglu
  • MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20140255484
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 12, 2014
    Publication date: September 11, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Unit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Oral tablet compositions of dexlansoprazole
    Patent number: 8758818
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: June 24, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Dual release oral tablet compositions of dexlansoprazole
    Patent number: 8753682
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: September 23, 2013
    Date of Patent: June 17, 2014
    Assignee: Sanovel Ilac Sanayi ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Modified release pharmaceutical compositions of dexlansoprazole
    Patent number: 8741345
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: June 3, 2014
    Assignee: Sanovel ILAC Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20140030328
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 30, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20140023709
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: September 23, 2013
    Publication date: January 23, 2014
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Oral tablet compositions of dexlansoprazole
    Patent number: 8563035
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: October 22, 2013
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Dual release oral tablet compositions of dexlansoprazole
    Patent number: 8563034
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: October 22, 2013
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • Extended release pharmaceutical compositions of levetiracetam
    Patent number: 8512746
    Abstract: Extended release pharmaceutical compositions of levetiracetam or pharmaceutically acceptable salts thereof in the form of a tablet comprising glyceryl behenate and a polymethacrylate polymer with at least one pharmaceutically acceptable excipient.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: August 20, 2013
    Assignee: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Hasan Ali Turp, Gulay Yelken, Asiye Sezgia, Ali Turkyilmaz, Levent Oner
  • ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20110274754
    Abstract: Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel llac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20110274752
    Abstract: Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel llac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE
    Publication number: 20110274753
    Abstract: Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.
    Type: Application
    Filed: May 5, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Ibrahim Murat Uzer, Alper Terkinli, Levent Oner
  • TRIMETAZIDINE FORMULATION WITH DIFFERENT RELEASE PROFILES
    Publication number: 20110274751
    Abstract: A multilayered solid oral pharmaceutical formulation of trimetazidine or a pharmaceutically acceptable salt or polymorph of trimetazidine wherein one layer of said formulation provides controlled release, while the other layer provides immediate release.
    Type: Application
    Filed: May 3, 2011
    Publication date: November 10, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Nur Pehlivan Akalin, Aylin Yildirim, Levent Oner
  • CONTROLLED-RELEASE FORMULATIONS OF PRAMIPEXOLE
    Publication number: 20110223245
    Abstract: A controlled-release pharmaceutical formulation, comprising pramipexole or a pharmaceutically acceptable salt of pramipexole, colloidal silicone dioxide, and glyceryl behenate.
    Type: Application
    Filed: March 10, 2011
    Publication date: September 15, 2011
    Applicant: Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Umit Cifter, Ali Turkyilmaz, Hasan Ali Turp, Gulay Yelken, Levent Oner
  • NIMESULIDE AND MUSCLE RELAXANT COMBINATIONS THEREOF
    Publication number: 20110053877
    Abstract: A topical pharmaceutical formulation made up of nimesulide or a pharmaceutically acceptable derivative of nimesulide, together with thiocolchicoside or a pharmaceutically acceptable derivative of thiocolchicoside. The present invention more particularly relates to pharmaceutical combinations of nimesulide and thiocolchicoside, in the form of topical gels, ointments, cream, sprays, or lotions with anti-inflammatory, analgesic, and myorelaxant activities.
    Type: Application
    Filed: August 31, 2010
    Publication date: March 3, 2011
    Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
    Inventors: Fatih Cakir, Ali Turkyilmaz, Levent Oner, Umit Cifter
  • EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM
    Publication number: 20110020445
    Abstract: Extended release pharmaceutical compositions of levetiracetam or pharmaceutically acceptable salts thereof in the form of a tablet comprising glyceryl behenate and a polymethacrylate polymer with at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: July 19, 2010
    Publication date: January 27, 2011
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Hasan Ali Turp, Gulay Yelken, Asiye Sezgia, Ali Turkyilmaz, Levent Oner
  • EZETIMIBE COMPOSITIONS
    Publication number: 20100234342
    Abstract: This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same.
    Type: Application
    Filed: March 15, 2010
    Publication date: September 16, 2010
    Applicant: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
    Inventors: Umit Cifter, Levent Oner, Ali Turkyilmaz, Ibrahim Murat Uzer, Gaye Ramazanoglu